Dr Bruce K Young


Dr. Bruce Young is internationally recognized as a leader and innovator in Obstetrics and Gynecology. He conducted the first intrauterine fetal transfusion for Rh disease at the NYU Medical Center in 1971, among the first in the US. He introduced prenatal genetic diagnosis and performed the first twenty genetic amniocenteses at the NYU Medical Center, founding the Prenatal Diagnosis program at NYU in 1972 and the Division of Maternal-Fetal Medicine in 1975. Several other clinical innovations followed, including fetal heart rate monitoring, fetal scalp blood pH and umbilical artery blood gas measurements for all laboring patients at Bellevue Hospital, and using the technique of intravenous infusion of magnesium sulfate for treatment of pre-eclampsia instead of giving it as an intramuscular injection. He also led the development of the world’s first Obstetrical ICU, and established the technique for fetoscopic closure of preterm ruptured membranes. He is a fellow of the American College of Obstetrics and Gynecology, and fellow of the American Gynecological and Obstetrical Society. He is the past President of the New York Obstetrical Society and the New York Perinatal Society. He served as the Director of Evaluation of the American Board of Maternal and Fetal Medicine. In 2014, he received the Berson award in clinical science of the New York University Medical School.

His 130 peer-reviewed publications cover various fetal heart rate patterns and their relationship with fetal acid base metabolism and adverse neonatal outcome, which is often referred to in the major obstetrics textbooks and Up to Date, estriol conjugates in amniotic fluid as a marker of fetal kidney function, fetoscopic surgery, risk assessment for high risk pregnancies, incompetent cervix, recurrent miscarriage, the fetal immune system, maternal-fetal immunologic cross-talk, and currently, human amniotic fluid derived stem cells. He has edited two text books on Maternal-Fetal Medicine and written two books for the more general reader. He directed the Division of Maternal-Fetal Medicine at NYU Medical Center until 2005 and the NYU Pregnancy Loss Prevention Center until 2019. He is presently Professor of Obstetrics and Gynecology at the New York University School of Medicine. 

He received his AB in Biology from Princeton University and his MD from New York University School of Medicine. 

We are passionate about delivering on the promise of amniotic fluid in shaping the future of regenerative medicine. We will deliver new therapies to patients where there are currently few treatment options, and provide innovative products for hair and skin care. 


Copyright 2021 © AMNICELL Corporation, LTD. All Rights Reserved | Privacy notice | Terms and condition | Copyright